Terns Pharmaceuticals, Inc.
TERN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,635 | -$24,093 | -$23,908 | -$21,799 |
| Dep. & Amort. | $111 | $108 | $169 | $214 |
| Deferred Tax | $34 | $0 | $34 | -$79 |
| Stock-Based Comp. | $0 | $3,028 | $0 | $3,021 |
| Change in WC | $1,365 | $2,069 | -$4,303 | $5,220 |
| Other Non-Cash | $3,352 | $8 | $3,562 | -$1,161 |
| Operating Cash Flow | -$19,773 | -$18,880 | -$24,446 | -$14,584 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$25,041 | -$119,348 |
| Inv. Sales/Matur. | $24,500 | $25,500 | $27,000 | $25,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $24,500 | $25,500 | $1,959 | -$94,348 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $318 | $74 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $6 | $0 | $304 |
| Financing Cash Flow | $0 | $324 | $74 | $304 |
| Forex Effect | $5 | -$1 | -$3 | -$69 |
| Net Chg. in Cash | $4,732 | $6,943 | -$22,416 | -$108,697 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $145,966 | $139,023 | $161,439 | $270,136 |
| End Cash | $150,698 | $145,966 | $139,023 | $161,439 |
| Free Cash Flow | -$19,773 | -$18,880 | -$24,446 | -$14,584 |